NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Joint Stock Company Kaspi.kz (NASDAQ: KSPI). Shareholders who purchased shares of KSPI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/joint-stock-company-kaspi-kz-loss-submission-form/?id=123874&from=3 ...

NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Symbotic Inc. (NASDAQ: SYM). Shareholders who purchased shares of SYM during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/symbotic-loss-submission-form-2/?id=123869&from=3 CLASS PERIOD: February 8, 2024 to No ...

Lawsuit Overview - The Gross Law Firm is issuing a notice to shareholders of BioAge Labs, Inc (NASDAQ: BIOA) who purchased shares during the specified class period [1] - Shareholders are encouraged to contact the firm regarding possible lead plaintiff appointment, though appointment is not required to partake in any recovery [1] - The class action lawsuit is on behalf of all shareholders who purchased stock pursuant and/or traceable to BioAge's registration statement for the initial public offering held on or about September 26, 2024 [3] Allegations - On December 6, 2024, BioAge announced the discontinuation of the ongoing STRIDES Phase 2 trial for azelaprag, its lead product candidate, due to safety concerns over elevated liver transaminase levels in participants [4] - This announcement was surprising as BioAge had highlighted azelaprag's potential in patients undergoing obesity therapy with incretin drugs at the time of its IPO less than three months earlier [4] - Following the news, BioAge's stock price declined from $20 09 per share on December 6, 2024 to $4 65 per share on December 7, 2024 [4] Next Steps for Shareholders - Shareholders who purchased BIOA shares during the specified timeframe can register to be enrolled in a portfolio monitoring software for status updates throughout the case lifecycle [5] - The deadline to seek to be a lead plaintiff is March 10, 2025, and there is no cost or obligation to participate in the case [5] About The Gross Law Firm - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investor rights [6] - The firm seeks recovery on behalf of investors who incurred losses due to false and/or misleading statements or the omission of material information by a company, leading to artificial inflation of the company's stock [6]

NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Aehr Test Systems, Inc. (NASDAQ: AEHR). Shareholders who purchased shares of AEHR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/aehr-loss-submission-form/?id=123870&from=3 CLASS PERIOD: January 9, 2024 ...

NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Five9, Inc. (NASDAQ: FIVN). Shareholders who purchased shares of FIVN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/five9-inc-loss-submission-form/?id=123871&from=3 CLASS PERIOD: June 4, 2024 to August ...

NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of ASP Isotopes Inc. (NASDAQ: ASPI). Shareholders who purchased shares of ASPI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/asp-isotopes-inc-loss-submission-form/?id=123866&from=3 CLASS PERIOD: October 30 ...

NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT). Shareholders who purchased shares of APLT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/applied-therapeutics-inc-loss-submission-form/?id=123867&from=3 CLASS P ...

NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Dentsply Sirona Inc. (NASDAQ: XRAY). Shareholders who purchased shares of XRAY during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/dentsply-loss-submission-form/?id=123868&from=3 CLASS PERIOD: May 6, 2021 to ...

NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN). Shareholders who purchased shares of REGN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/regeneron-pharmaceuticals-inc-loss-submission-form/?id=123865&from ...

NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Celsius Holdings, Inc. (NASDAQ: CELH). Shareholders who purchased shares of CELH during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/celsius-holdings-inc-loss-submission-form-2/?id=123863&from=3 CLASS PERIOD: ...